Epilepsy-associated digenic variants affecting an actin/mitochondria/glutamate pathway promote seizure susceptibility
Journal of Clinical Investigation · 01.09.2026 · 136 (17)
DOI: 10.1172/jci198696 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 16.07.2026. Verfasst von Shenzhao Lu und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Actins, Glutamic Acid, Seizures, Mitochondria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NIA NIH HHS, NIH.
Abstract (Originalsprache)
Epilepsy affects approximately 50 million people worldwide, yet more than half of individuals with a presumed genetic cause still lack a molecular diagnosis despite the identification of over 1,000 monogenic epilepsy genes. This diagnostic gap is unlikely to be resolved by improved variant detection alone, suggesting that variants affecting the same biological pathway may combine to cause disease. By studying epilepsy-associated actin regulatory genes, we identified a conserved actin/mitochondria/glutamate (AMG) pathway. We demonstrate that reduced actin polymerization promoted DRP1-mediated mitochondrial fission, increased ROS levels, and enhanced glutamatergic transmission, leading to seizures. The glial innate immune pathway, a recently recognized contributor to epilepsy, is activated when the AMG pathway is affected. Reducing mitochondrial fission with the mitochondria division inhibitor (Mdivi-1), or suppressing ROS with N -acetyl-l-cysteine amide (NACA), significantly alleviated seizures. Importantly, digenic heterozygous loss-of-function variants in AMG pathway genes combined to cause seizures, and individuals with epilepsy of unknown etiology showed an increased burden of such variants when compared with the controls. Modeling patient-specific digenic combinations in Drosophila confirmed that many combinations promote seizure susceptibility. Together, these findings establish the AMG pathway as a mechanistic framework for identifying digenic etiologies in epilepsy and highlight potential therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
- Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, Texas, USA.
- Department of Neurology, Baylor College of Medicine, Houston, Texas, USA.
- Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
- Baylor Genetics Laboratories, Houston, Texas, USA.
- Department of Neuroscience, Baylor College of Medicine, Houston, Texas, USA.
Förderung
- NICHD NIH HHS
- NIA NIH HHS
- NIH
- Huffington Foundation
- Neurogenetics Chair of the Texas Children’s Neurological Research Institute
- NRI Zoghbi Scholar Award
- the TNPO2 Foundation
- the BrightFocus Foundation
Zitieren
APA
Lu, S., Ma, M., Hannan, S. B., Deng, M., Chen, H., Yu, Z., Goodman, L. D., Kim, H., Zhao, Y., Dubey, S. K., Lin, W. W., Pan, X., Dutta, D., Cuddapah, V. A., Rosenfeld, J. A., Luo, X., Liu, Z., Shulman, J. M., & Bellen, H. J. (2026). Epilepsy-associated digenic variants affecting an actin/mitochondria/glutamate pathway promote seizure susceptibility. Journal of Clinical Investigation, 136(17). https://doi.org/10.1172/jci198696
Vancouver
Lu S, Ma M, Hannan SB, Deng M, Chen H, Yu Z, et al. Epilepsy-associated digenic variants affecting an actin/mitochondria/glutamate pathway promote seizure susceptibility. Journal of Clinical Investigation. 2026;136(17). doi:10.1172/jci198696
BibTeX
@article{Lu2026,
author = {Lu, Shenzhao and Ma, Mengqi and Hannan, Shabab B and Deng, Mingxi and Chen, Hu and Yu, Zhijian and Goodman, Lindsey D and Kim, Haein and Zhao, Yun and Dubey, Sandeep Kumar and Lin, Wen-Wen and Pan, Xueyang and Dutta, Debdeep and Cuddapah, Vishnu Anand and Rosenfeld, Jill A and Luo, Xi and Liu, Zhandong and Shulman, Joshua M and Bellen, Hugo J},
title = {Epilepsy-associated digenic variants affecting an actin/mitochondria/glutamate pathway promote seizure susceptibility},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {17},
doi = {10.1172/jci198696}
}
EUVIMED